Skip to main content
. 2016 May 11;7(27):41265–41273. doi: 10.18632/oncotarget.9283

Table 3. Outcomes of patients in the L-C and H-C groups.

Variable L-C Group (n = 550) H-C Group (n = 550) X2 P
NO. % NO. %
No. of clip
 1 470 85.5 453 82.4 1.946 0.163
 2 80 14.5 97 17.6
Overall complications 47 8.5 52 9.5 0.278 0.598
IAA 29 5.3 33 6.0 1.807 0.179
Stump leak 1 0.2 2 0.4 0.334 0.563
Superficial wound infection 14 2.5 12 2.2 0.158 0.691
Post-operative abdominal pain 3 0.5 5 0.9 0.504 0.478
Overall re-intervention 52 9.5 60 10.9 0.636 0.425
Percutaneous and/or transrectal drainage 3 0.5 2 0.4 0.201 0.654
Re-operation 11 2.0 13 2.4 0.17 0.680
Prolonged intravenous antibiotics 33 6.0 41 7.5 0.927 0.336
Readmissions 5 0.9 4 0.7 0.112 0.738
Othersa 23 4.2 27 4.9 0.335 0.563
Overall adverse events 122 22.2 139 25.3 1.452 0.228
Duration of operation ± SD, min 41.4 ± 19.8 40.6 ± 20.3 1.012b 0.679
Duration of hospital stay ± SD, days 3.56 ± 2.11 3.49 ± 2.33 1.135b 0.531

Abbreviations:

a

other adverse events including enteritis, persistent elevated inflammatory parameters, sepsis with MRSA, persistent diarrhea, intra-abdominal fluid collection, and constipation;

b

T-test result.